News
HYTNF
0.100
NaN%
--
HYTN Drug Establishment Licence Expanded to Include Active Pharmaceutical Ingredients and Pharmaceutical Oils
Barchart · 05/07 16:00
HYTN Successfully Exports GMP-Manufactured Vape Cartridges
Barchart · 04/30 16:01
HYTN Announces Proposed Spin-Out of BPC-157 Peptide Drug Development Business
Barchart · 04/23 16:01
HYTN Introduces HARd Remediation to GMP Processing Services, Releases Product in Germany
Barchart · 04/17 16:00
HYTN Successfully Releases Cannabis Products in Germany and Accepts Reorder
Barchart · 03/27 17:46
HYTN Announces Extension of Marketing Program
Barchart · 03/02 16:00
HYTN Announces Engagement of Marketing and Communications Services Provider
Barchart · 01/09 16:00
HYTN Welcomes U.S. Executive Order Initiating Cannabis Reclassification to Schedule III
Barchart · 12/18/2025 16:01
Weekly Report: what happened at HYTNF last week (0908-0912)?
Weekly Report · 09/15/2025 12:19
Weekly Report: what happened at HYTNF last week (0901-0905)?
Weekly Report · 09/08/2025 12:22
Weekly Report: what happened at HYTNF last week (0825-0829)?
Weekly Report · 09/01/2025 12:14
Weekly Report: what happened at HYTNF last week (0818-0822)?
Weekly Report · 08/25/2025 12:32
Weekly Report: what happened at HYTNF last week (0811-0815)?
Weekly Report · 08/18/2025 12:19
Weekly Report: what happened at HYTNF last week (0804-0808)?
Weekly Report · 08/11/2025 12:30
Weekly Report: what happened at HYTNF last week (0728-0801)?
Weekly Report · 08/04/2025 12:34
Weekly Report: what happened at HYTNF last week (0721-0725)?
Weekly Report · 07/28/2025 12:34
Weekly Report: what happened at HYTNF last week (0714-0718)?
Weekly Report · 07/21/2025 12:20
Weekly Report: what happened at HYTNF last week (0707-0711)?
Weekly Report · 07/14/2025 12:34
Weekly Report: what happened at HYTNF last week (0630-0704)?
Weekly Report · 07/07/2025 12:21
Weekly Report: what happened at HYTNF last week (0623-0627)?
Weekly Report · 06/30/2025 12:31
More
Webull provides a variety of real-time HYTNF stock news. You can receive the latest news about HYTN Innovations Inc through multiple platforms. This information may help you make smarter investment decisions.
About HYTNF
HYTN Innovations Inc. is a Canada-based pharmaceutical company. The Company is specialized in the formulation, manufacturing, marketing, and sale of products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids and psilocybe-derived tryptamines. It is engaged in the development of the sparkling tetrahydrocannabinol and the cannabidiol beverage business. Its product and services include GMP Cannabis Processing, GMP Psilocybin Mushroom Manufacturing, GMP Active Pharmaceutical Ingredient (API) Fabrication, Cannabis Consumer Packaged Goods, and Elevation Technology. The Company enables global market access for non-sterile pharmaceuticals. It has a manufacturing facility based in Kelowna, British Columbia. The Company’s subsidiaries include HYTN Innovations Inc., HYTN Beverage Corp, HYTN Cannabis Inc., 1306562 B.C. Ltd., and Prism Scientific Labs Inc.